Struck = removed from the bill ยท
added = the amendment's new text.
AnHB2047 ActFA1 ENROLLEDStinsonPr-AO(Untimely Filed) 3/21/2025 11:28:22 am FLOOR AMENDMENT HOUSE BILLOF NO.REPRESENTATIVES State of Oklahoma SPEAKER:
CHAIR:
I move to amend HB2047 Of the printed Bill Page Section Lines Of the Engrossed Bill By deleting the content of the entire measure, and by inserting in lieu thereof the following language:
AMEND TITLE TO CONFORM TO AMENDMENTS Amendment submitted by:
Preston Stinson Adopted:
_____________________________ ______________________Reading Clerk___ STATE OF OKLAHOMA 1st Session of the 60th Legislature (2025) FLOOR SUBSTITUTE FOR HOUSE BILL NO.
Stinson,Stinson Archer, Roe, and Miller of the House and Hines of the Senate 8 FLOOR SUBSTITUTE An Act relating to schools;
SUBJECT:BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
Schools BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
SECTIONReq. 2.
No.
13312 Page 1 SECTION 2.
The school district to inform the parent or guardian of the student, in writing, that the school district and its employees and agentsReq. shall incur no liability as a result of any injury arising from the self-administration of medication by the student;
No.
13312 Page 2 agents shall incur no liability as a result of any injury arising from the self-administration of medication by the student;
the school district to inform the parent or guardian of each student, in writing, that a school nurse or school employee trained by a health care professional or trained in correlation with the State Department of Health's Diabetes Management Annual School Training Program pursuant to subsection G of this section may administer, with parent or guardian permission but without a health care provider order, an Epinephrine injection to a student whom the school nurse or ENR.trained school employee in good faith believes is having an anaphylactic reaction, b.
H.a waiver of liability executed by a parent or guardian be on file with the school district prior to the Req.
B.No.
NO.13312 Page 3 administration of an Epinephrine injection pursuant to paragraph 1 of this subsection, and c.
2047 Page 2 trained school employee in good faith believes is having an anaphylactic reaction, b.
a waiver of liability executed by a parent or guardian be on file with the school district prior to the administration of an Epinephrine injection pursuant to paragraph 1 of this subsection, and c.
A licensed physician who has prescriptive authority may write a prescription for Epinephrine injectors and inhalers and spacersReq. or holding chambers to the school district in the name of the district as a body corporate specified in Section 5-105 of this title which shall be maintained at each school site.
No.
13312 Page 4 spacers or holding chambers to the school district in the name of the district as a body corporate specified in Section 5-105 of this title which shall be maintained at each school site.
The school district may maintain at each school a minimum of two Epinephrine injectors devices and two inhalers with spacers or ENR.holding chambers in a secure location.
H.
B.
NO.
2047 Page 3 holding chambers in a secure location.
The model policies shall include, at a minimum, required annual training for teachers and school employees who are directly responsible for students on theReq. topics of food allergies, recognizing anaphylaxis, and instruction on how to administer Epinephrine.
No.
13312 Page 5 the topics of food allergies, recognizing anaphylaxis, and instruction on how to administer Epinephrine.
and ENR.4.
H."Inhaler" means a device that delivers a bronchodilator to alleviate symptoms of respiratory distress that is manufactured in Req.
B.No.
NO.13312 Page 6 the form of a metered-dose inhaler or dry-powder inhaler and that may include a spacer or holding chamber that attaches to the inhaler to improve the delivery of the bronchodilator.
2047 Page 4 4.
"Inhaler" means a device that delivers a bronchodilator to alleviate symptoms of respiratory distress that is manufactured in the form of a metered-dose inhaler or dry-powder inhaler and that may include a spacer or holding chamber that attaches to the inhaler to improve the delivery of the bronchodilator.
ENR.60-1-13312 SW 03/17/25 Req.
H.No.
B.13312 Page 7
NO.
2047 Page 5 Passed the House of Representatives the 26th day of March, 2025.
Presiding Officer of the House of Representatives Passed the Senate the 6th day of May, 2025.
Presiding Officer of the Senate OFFICE OF THE GOVERNOR Received by the Office of the Governor this ____________________ day of ___________________, 20_______, at _______ o'clock _______ M.
By:
_________________________________ Approved by the Governor of the State of Oklahoma this _________ day of ___________________, 20_______, at _______ o'clock _______ M.
_________________________________ Governor of the State of Oklahoma OFFICE OF THE SECRETARY OF STATE Received by the Office of the Secretary of State this __________ day of ___________________, 20_______, at _______ o'clock _______ M.
By:
_________________________________ ENR.
H.
B.
NO.
2047 Page 6